Compare Stocks

Ecosciences, Inc. engages in the development, production, and sale of environmentally focused wastewater products to food and sanitation industries, as well as residential consumers in the United States and internationally. It produces organic tablets and powders to be used regularly and in lieu of harmful chemical cleaning products in grease trap and septic tank systems. The company provides bio-remediation services for sewers, sludge ponds, septic tanks, lagoons, farms, car washes, portable sanitation facilities, grease tanks, lakes, and ponds. Its products include Tank-Eze Wastewater Tablets, which provide active oxygen, nutrients, buffers, and safe aerobic microorganisms to clean, control odor, and keep wastewater systems running with reduced downtime; Trap-Eze Grease Trap Tablets that offer active oxygen, nutrients, buffers, and safe anaerobic and aerobic microorganisms to clean, deodorize, and keep grease traps running with reduced downtime; and Wash-Eze Car Wash Tablet, which reduces noxious odors, spotting, and other problems associated with the use of reclaimed water. The company primarily sells its products to municipalities, retail consumers, commercial and industrial users, food processors, hospitals, supermarkets, restaurants, and the janitorial supply industry through a network of master distributors, full line distributors, and sales representatives. Ecosciences, Inc. was incorporated in 2010 and is based in Jericho, New York.

Elah Holdings, Inc., a holding company, focuses on acquiring profitable businesses in the commercial and industrial markets. The company was formerly known as Real Industry, Inc. and changed its name to Elah Holdings, Inc. in May 2018. Elah Holdings, Inc. is based in Dallas, Texas.

Green Oasis Environmental, Inc., an environmental company, acquires companies with growing corporate revenues, significant technological advancements, and global market share. It focuses on acquiring technology and/or operations concerning the remediation of slop oil, waste engine oil, and tank bottom oils. The company, through its subsidiary, Custom Carbon Processing (CCP), Inc., provides slop-oil processing/recycling services in Wyoming and Montana. It uses its technology to separate oil from waste water during production of hydrocarbons; cleans and separates solids from tank bottoms and flow back fluids; and produces pipeline spec oil from oil based drilling muds. The company was incorporated in 1991 and is headquartered in Edmonton, Canada.

Viela Bio, Inc., a clinical-stage biotechnology company, engages in the research and development of treatments for severe inflammation and autoimmune diseases in the United States. The company's lead product candidate is inebilizumab, a humanized monoclonal antibody for neuromyelitis optica spectrum disorder, kidney transplant desensitization, myasthenia gravis, and IgG4-related diseases. It is also developing VIB4920 for kidney transplantation rejection and sjögren's syndrome; and VIB7734 for cutaneous lupus erythematosus. Viela Bio, Inc. has a strategic collaboration with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases in Japan, Thailand, South Korea, Indonesia, Vietnam, Malaysia, the Philippines, Singapore, and Taiwan. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.